Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

As of 2020, more than 1.9 million people around the world were diagnosed with colorectal cancer each year, making it the third most common cancer globally. Now, a new study presented at the 2025 ...

Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, reprogrammed using CRISPR gene editing to attack tumors more aggressively.

Please provide your email address to receive an email when new articles are posted on . Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk ...

People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. The findings were present the at the annual meeting of the American ...

SAN ANTONIO, Texas (Ivanhoe Newswire) - Colorectal cancer often spreads to the liver, requiring prolonged chemotherapy. But now, doctors are turning to hepatic artery infusion. This therapy delivers ...

Neoadjuvant therapy for patients with metastatic colon cancer with single-organ liver or lung lesions was associated with improved overall survival in comparison with adjuvant therapy, according to ...

Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients The following represents disclosure information provided by authors of this manuscript. All ...

An interview with Dr. Nancy Baxter from the University of Melbourne in Melbourne, Australia, and Dr. Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston, MA, co-chairs on “Adjuvant Therapy ...

The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options. When Mia Balko, 48, ...